Literature DB >> 30392296

[Surveillance of bacterial resistance in children and newborns across China from 2014 to 2017].

.   

Abstract

Objective: To study bacterial resistance in children and newborns aged less than 14 years across China from 2014 to 2017.
Methods: Bacterial resistance data on children and newborns were extracted from the national bacterial resistance surveillance reports from 2014 to 2017. Resistance trends in children and newborns were analyzed over the past four years, and compared with the adult and elderly groups.
Results: Among all strains, the isolates collected from children and newborns from 2014 to 2017 accounted for 16.2%, 13.8%, 15.3% and 16.3%, respectively. The proportions of gram-positive bacteria among strains isolated from children and newborns, which were apparently higher than that of the adult and elderly groups, were 42.6%, 44.3%, 45.8% and 45.5%, respectively. The top five isolates of gram-positive bacteria were Staphylococcus aureus, Streptococcus pneumoniae, coagulase-negative staphylococci, Enterococcus faecium and E. faecalis. The top five isolates of gram-negative bacteria were Escherichia coli, Klebsiella pneumonia, Haemophilus influenzae, Pseudomonas aeruginosa and Acinetobacter baumannii. The proportion of urine-derived bacteria isolated from children and newborns (6.1%-7.1%) was apparently lower than that of the adult and elderly groups, while sputum (49.2%-52.8%) and blood-derived (11.4%-13.8%) were higher than the adult group. The prevalence of cefotaxime-resistant E. coli and K. pneumoniae decreased from 58.3% to 52.0% and 51.2% to 45.0%, respectively. The prevalence of imipenem-resistant E. coli and K. pneumoniae increased from 1.2% to 1.9% and 5.6% to 8.8%, respectively. The prevalence of imipenem-resistant P. aeruginosa increased from 11.0% to 12.4%, however, the prevalence of imipenem-resistant A. baumannii decreased from 27.2% to 24.6%. The prevalence of methicillin-resistant S. aureus increased from 27.5% to 29.5%. The prevalence of vancomycin-resistant-E.faecalis/E.faecium decreased from 0.6% to 0.2% and 0.9% to 0.3%, respectively. The proportion of non-cerebrospinal fluid-derived penicillin-resistant S. pneumoniae decresed from 5.1% to 2.7%. Conclusions: The prevalence of several drug-resistant bacteria isolated from children and newborns were decreasing, but the prevalence of imipenem-resistant E. coli, imipenem-resistant K. pneumoniae and methicillin-resistant S. aureus increased slowly. It is still necessary to strengthen antibiotics rational application management and hospital infection control, and maintain good practice in bacterial resistance surveillance work.

Entities:  

Keywords:  Antimicrobial agents; Bacteria; Children and newborns; China Antimicrobial Resistance Surveillance System; Resistance

Mesh:

Substances:

Year:  2018        PMID: 30392296     DOI: 10.3760/cma.j.issn.0376-2491.2018.40.013

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  4 in total

1.  The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections.

Authors:  Olaniyi Ayobami; Niklas Willrich; Annicka Reuss; Tim Eckmanns; Robby Markwart
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

2.  Surveillance of Multidrug-Resistant Bacterial Infections in Non-Adult Patients - Zhejiang Province, China, 2014-2019.

Authors:  Yuchen Wu; Shi Chen; Jiaping Li; Chang Cai; Hanyu Wang; Mingming Zhou; Junmin Cao; Qiang Wang; Shenghai Wu; Shibiao Ding; Xiaofei Zhao; Long Sun; Qingfeng Hu; Hongwei Zhou; Xiang Qian; Qing Yang; Sheng Chen; Rong Zhang
Journal:  China CDC Wkly       Date:  2021-11-19

3.  Prevalence and risk factors for antibiotic utilization in Chinese children.

Authors:  Shasha Guo; Qiang Sun; Xinyang Zhao; Liyan Shen; Xuemei Zhen
Journal:  BMC Pediatr       Date:  2021-06-01       Impact factor: 2.125

4.  Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.

Authors:  Jian Peng; Huiling Long; Weiwei Liu; Zhaoying Wu; Tao Wang; Zhu Zeng; Guo Guo; Jianwei Wu
Journal:  Infect Drug Resist       Date:  2019-08-05       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.